Schizophrenia
Showing NaN - NaN of 113
Bipolar Disorder, Schizophrenia, Agitation,Psychomotor Trial in Little Rock, Rogers (Sublingual film containing Igalmi)
Recruiting
- Bipolar Disorder
- +4 more
- Sublingual film containing Igalmi
-
Little Rock, Arkansas
- +1 more
Sep 21, 2023
Agitation,Psychomotor, Bipolar I Disorder, Bipolar II Disorder Trial in United States (BXCL501, Matching Placebo)
Recruiting
- Agitation,Psychomotor
- +5 more
- BXCL501
- Matching Placebo
-
Little Rock, Arkansas
- +16 more
Jan 31, 2023
Schizophrenia Trial in San Diego, Richardson (CVL-231 10 mg, Required CVL-231 30 mg, Placebo)
Recruiting
- Schizophrenia
- CVL-231 10 mg
- +2 more
-
Little Rock, Arkansas
- +15 more
Jan 27, 2023
Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules)
Recruiting
- Schizophrenia
- Xanomeline and Trospium Chloride Capsules
-
Little Rock, Arkansas
- +52 more
Jan 17, 2023
Schizophrenia Trial in Worldwide (SEP-363856 50mg, SEP-363856 75mg, Placebo)
Recruiting
- Schizophrenia
- SEP-363856 50mg
- +2 more
-
Little Rock, Arkansas
- +58 more
Dec 12, 2022
Schizophrenia Trial in Worldwide (SEP-363856 75mg, SEP-363856 100mg, Placebo)
Recruiting
- Schizophrenia
- SEP-363856 75mg
- +2 more
-
Little Rock, Arkansas
- +63 more
Dec 12, 2022
Schizophrenia Trial (CVL-231 30 mg)
Enrolling by invitation
- Schizophrenia
- CVL-231 30 mg
-
Bentonville, Arkansas
- +16 more
Dec 7, 2022
Schizophrenia Trial in United States (SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole))
Recruiting
- Schizophrenia
- SEP-363856
- Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
-
Little Rock, Arkansas
- +6 more
Nov 11, 2022
Schizophrenia Trial in Worldwide (BI 425809, Placebo)
Completed
- Schizophrenia
- BI 425809
- Placebo
-
Little Rock, Arkansas
- +50 more
Nov 7, 2022
Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules, Placebo)
Recruiting
- Schizophrenia
- Xanomeline and Trospium Chloride Capsules
- Placebo
-
Little Rock, Arkansas
- +18 more
Aug 12, 2022
Schizophrenia, Schizophrenia; Psychosis Trial in Ukraine, United States (Xanomeline and Trospium Chloride Capsules, Placebo)
Recruiting
- Schizophrenia
- Schizophrenia; Psychosis
- Xanomeline and Trospium Chloride Capsules
- Placebo
-
Bentonville, Arkansas
- +28 more
Aug 12, 2022
Blood Pressure, Schizophrenia Trial in United States (CVL-231)
Active, not recruiting
- Blood Pressure
- Schizophrenia
-
Bentonville, Arkansas
- +9 more
Jul 11, 2022
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156
Recruiting
- Schizophrenia
- +11 more
- LY03010 156 mg treatment group, deltoid
- +3 more
-
Little Rock, Arkansas
- +8 more
Apr 11, 2022
Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)
Active, not recruiting
- Schizophrenia
- +2 more
- ALKS 3831
-
Little Rock, Arkansas
- +85 more
Feb 10, 2022
Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +
Completed
- Schizophrenia
- Alcohol Use Disorder
- Samidorphan + olanzapine (ALKS 3831)
- Placebo + olanzapine
-
Little Rock, Arkansas
- +70 more
Sep 14, 2021
Schizophrenia Trial in Bulgaria, Czechia, United States (Samidorphan (Low Dose), Samidorphan (Medium Dose), Samidorphan (High
Completed
- Schizophrenia
- Samidorphan (Low Dose)
- +4 more
-
Little Rock, Arkansas
- +60 more
Sep 10, 2021